MedTrace Logo

Evaluation of Kinesophobia in Patients With Metabolic Syndrome

NCT04123132 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2020-01-10

No results posted yet for this study

Summary

Metabolic syndrome (MS) is a public health problem characterized by central obesity, increased blood pressure and triglyceride levels, decreased blood HDL levels and the presence of insulin resistance (1).Kinesiophobia is a fear of irrational movement that develops because of its belief in susceptibility to injury and is associated with low levels of physical activity. Considering that exercise improves metabolic processes in people with MS, we aimed to evaluate the presence of kinesophobia in patients with MS.

Patients aged 45-65 years diagnosed with metabolic syndrome and healthy controls will be included in the study. Patients with rheumatic and neurological diseases,history of trauma, gonarthrosis, lumbar disc hernia, previous fractures, fibromyalgia and those who have experienced pain for the last week will be excluded. The participants will be filled in the Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale, and the Tampa Kinesiophobia Scale. 48 patients with MS and 48 healthy participants will be included in the study.

Conditions

  • Kinesiophobia
  • Metabolic Syndrome

Interventions

OTHER

Kinesiophobia

The presence of kinesiofobia in patients with metabolic syndrome

Sponsors & Collaborators

  • Erol Olcok Corum Training and Research Hospital

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-25
Primary Completion
2020-02-01
Completion
2020-02-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04123132 on ClinicalTrials.gov